PodcastOne, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that PodcastOne, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | ($6.46M) | Jul 2, 2025 |
| FY2025 | Mar 31, 2024 | ($14.73M) | Jul 2, 2025 |
| FY2024 | Mar 31, 2023 | ($6.97M) | Jul 1, 2024 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | ($6.43M) | Jul 2, 2025 |
| FY2025 | Mar 31, 2024 | ($5.01M) | Jul 2, 2025 |
| FY2024 | Mar 31, 2023 | ($1.84M) | Jul 1, 2024 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $52.0K | Jul 2, 2025 |
| FY2025 | Mar 31, 2024 | $85.0K | Jul 2, 2025 |
| FY2024 | Mar 31, 2023 | $312.0K | Jul 1, 2024 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | ($212.0K) | Jul 2, 2025 |
| FY2025 | Mar 31, 2024 | $2.21M | Jul 2, 2025 |
| FY2024 | Mar 31, 2023 | ($4.70M) | Jul 1, 2024 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $154.0K | Jul 2, 2025 |
| FY2025 | Mar 31, 2024 | $318.0K | Jul 2, 2025 |
| FY2024 | Mar 31, 2023 | $219.0K | Jul 1, 2024 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $21.20M | Jul 2, 2025 |
| FY2025 | Mar 31, 2024 | $24.13M | Jul 2, 2025 |
| FY2024 | Mar 31, 2023 | $28.23M | Jul 1, 2024 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $6.05M | Jul 2, 2025 |
| FY2025 | Mar 31, 2024 | $7.78M | Jul 2, 2025 |
| FY2024 | Mar 31, 2023 | $21.11M | Jul 1, 2024 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $15.14M | Jul 2, 2025 |
| FY2025 | Mar 31, 2024 | $16.34M | Jul 2, 2025 |
| FY2025 | Mar 31, 2023 | $7.12M | Jul 2, 2025 |
| FY2024 | Mar 31, 2022 | $13.09M | Jul 1, 2024 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $12.04M | Jul 2, 2025 |
| FY2025 | Mar 31, 2024 | $12.04M | Jul 2, 2025 |
| FY2024 | Mar 31, 2023 | $12.04M | Jul 1, 2024 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | ($36.07M) | Jul 2, 2025 |
| FY2025 | Mar 31, 2024 | ($29.61M) | Jul 2, 2025 |
| FY2024 | Mar 31, 2023 | ($12.67M) | Jul 1, 2024 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $1.08M | Jul 2, 2025 |
| FY2025 | Mar 31, 2024 | $1.45M | Jul 2, 2025 |
| FY2024 | Mar 31, 2023 | $3.56M | Jul 1, 2024 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 0 | Jul 2, 2025 |
| FY2025 | Mar 31, 2024 | 0 | Jul 2, 2025 |
| FY2024 | Mar 31, 2023 | 0 | Jul 1, 2024 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 26.02M | Jul 2, 2025 |
| FY2025 | Mar 31, 2024 | 23.61M | Jul 2, 2025 |
| FY2024 | Mar 31, 2023 | 20.00M | Jul 1, 2024 |